HomeDealsNegotiationsPolicyPipelineMoneyPeopleDataThe WeekPharmTech 100Deal TrackerResearch
The Week

Regulatory tracker: Novo's oral GLP-1 picks up UK approval

In this tracker, Fierce Pharma is recording the regulatory progress of in-market products, including expansions into key geographies and new indications. Some of these updates may not meet the bar for standalone stories, but we think they are still worth mentioning.

By FiercePharma · Jun 14, 2026 · via FiercePharma

This is an aggregated industry headline. Read the full story at FiercePharma →

RxInsider combines reported facts with industry analysis and informed inference. Forward-looking reads, market commentary, and interpretive framing reflect analysis of available reporting and known facts, not confirmed outcomes.

Tags
theweekformat:headlineheadlineFiercePharma
The Insider - Weekly pharma intelligence
Deals, negotiations, and policy analysis. Delivered when it matters.
No sponsored content. No noise. Unsubscribe anytime.
More from The Week
All The Week →
'Not simply saving cost': Inside Astellas CEO's 5-year strategy to counter Xtandi's patent cliff
The WeekFierceBiotech ↗
'Not simply saving cost': Inside Astellas CEO's 5-year strategy to counter Xtandi's patent cliff
Staring down a $6 billion patent cliff for its prostate cancer drug Xtandi, Astellas aims to counter the inevi…
Jun 14, 2026
STAT’s focus: Obesity drugs crowd pipeline as peptides gain ground
The WeekBriefing
STAT’s focus: Obesity drugs crowd pipeline as peptides gain ground
STAT News spotlighted obesity drugs in development, peptide therapies going mainstream, and a record biotech I…
Jun 14, 2026
The WeekAJMC ↗
Paul Richardson, MD, Calls Mezigdomide "CAR T in a Pill" for Patients With R/R Multiple Myeloma
Paul Richardson, MD, Calls Mezigdomide "CAR T in a Pill" for Patients With R/R Multiple Myeloma…
Jun 14, 2026